Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?

被引：1
|
作者：
Fallet, Vincent [1 ]
Sanchis-Borja, Mateo [1 ]
Benusiglio, Patrick R. [2 ,3 ]
Cadranel, Jacques [4 ]
机构：
[1] Sorbonne Univ, Dept Pneumol & Thorac Oncol, Assistance Publ Hop Paris & GRC 4, Tenon Hosp, Paris, France
[2] Grp Hosp Pitie Salpetriere, APHP, Dept Genet, Oncogenet Consulting Oncogenet Funct Unit, Paris, France
[3] Sorbonne Univ, Ctr Rech Saint Antoine, Unite Mixte Rech Sci 938 & SIRIC CURAMUS, INSERM,Equipe Instabilites Microsatellites & Can, Paris, France
[4] Sorbonne Univ, Dept Pneumol & Thorac Oncol, Tenon Hosp, Assistance Publ Hop Paris & GRC 4, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 22期
关键词：
MUTATIONS;
D O I：
10.1200/JCO.22.00488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2508 / +
页数：2
相关论文
共 50 条
  • [31] The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers
    Yael Laitman
    Karoline B. Kuchenbaecker
    Johanna Rantala
    Frans Hogervorst
    Susan Peock
    Andrew K. Godwin
    Adalgeir Arason
    Tomas Kirchhoff
    Kenneth Offit
    Claudine Isaacs
    Rita K. Schmutzler
    Barbara Wappenschmidt
    Heli Nevanlinna
    Xiaoqing Chen
    Georgia Chenevix-Trench
    Sue Healey
    Fergus Couch
    Paolo Peterlongo
    Paolo Radice
    Katherine L. Nathanson
    Maria Adelaide Caligo
    Susan L. Neuhausen
    Patricia Ganz
    Olga M. Sinilnikova
    Lesley McGuffog
    Douglas F. Easton
    Antonis C. Antoniou
    Ido Wolf
    Eitan Friedman
    Breast Cancer Research and Treatment, 2012, 132 : 1119 - 1126
  • [32] BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
    Lee, Anbok
    Moon, Byung-In
    Kim, Tae Hyun
    ANNALS OF LABORATORY MEDICINE, 2020, 40 (02) : 114 - 121
  • [33] Increased Rate of Phenocopies in All Age Groups in BRCA1/BRCA2 Mutation Kindred, but Increased Prospective Breast Cancer Risk Is Confined to BRCA2 Mutation Carriers
    Evans, D. Gareth R.
    Ingham, Sarah L.
    Buchan, Iain
    Woodward, Emmar R.
    Byers, Helen
    Howell, Anthony
    Maher, Eamonn R.
    Newman, William G.
    Lalloo, Fiona
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (12) : 2269 - 2276
  • [34] Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
    Barnes, Daniel R.
    Rookus, Matti A.
    McGuffog, Lesley
    Leslie, Goska
    Mooij, Thea M.
    Dennis, Joe
    Mavaddat, Nasim
    Adlard, Julian
    Ahmed, Munaza
    Aittomaki, Kristiina
    Andrieu, Nadine
    Andrulis, Irene L.
    Arnold, Norbert
    Arun, Banu K.
    Azzollini, Jacopo
    Balmana, Judith
    Barkardottir, Rosa B.
    Barrowdale, Daniel
    Benitez, Javier
    Berthet, Pascaline
    Bialkowska, Katarzyna
    Blanco, Amie M.
    Blok, Marinus J.
    Bonanni, Bernardo
    Boonen, Susanne E.
    Borg, Ake
    Bozsik, Aniko
    Bradbury, Angela R.
    Brennan, Paul
    Brewer, Carole
    Brunet, Joan
    Buys, Saundra S.
    Caldes, Trinidad
    Caligo, Maria A.
    Campbell, Ian
    Christensen, Lise Lotte
    Chung, Wendy K.
    Claes, Kathleen B. M.
    Colas, Chrystelle
    Collonge-Rame, Marie-Agnes
    Cook, Jackie
    Daly, Mary B.
    Davidson, Rosemarie
    de la Hoya, Miguel
    de Putter, Robin
    Delnatte, Capucine
    Devilee, Peter
    Diez, Orland
    Ding, Yuan Chun
    Domchek, Susan M.
    GENETICS IN MEDICINE, 2020, 22 (10) : 1653 - 1666
  • [35] Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers
    Julika Borde
    Yael Laitman
    Britta Blümcke
    Dieter Niederacher
    Konstantin Weber-Lassalle
    Christian Sutter
    Andreas Rump
    Norbert Arnold
    Shan Wang-Gohrke
    Judit Horváth
    Andrea Gehrig
    Gunnar Schmidt
    Véronique Dutrannoy
    Juliane Ramser
    Julia Hentschel
    Alfons Meindl
    Christopher Schroeder
    Barbara Wappenschmidt
    Christoph Engel
    Karoline Kuchenbaecker
    Rita K. Schmutzler
    Eitan Friedman
    Eric Hahnen
    Corinna Ernst
    BMC Cancer, 22
  • [36] Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers
    Borde, Julika
    Laitman, Yael
    Bluemcke, Britta
    Niederacher, Dieter
    Weber-Lassalle, Konstantin
    Sutter, Christian
    Rump, Andreas
    Arnold, Norbert
    Wang-Gohrke, Shan
    Horvath, Judit
    Gehrig, Andrea
    Schmidt, Gunnar
    Dutrannoy, Veronique
    Ramser, Juliane
    Hentschel, Julia
    Meindl, Alfons
    Schroeder, Christopher
    Wappenschmidt, Barbara
    Engel, Christoph
    Kuchenbaecker, Karoline
    Schmutzler, Rita K.
    Friedman, Eitan
    Hahnen, Eric
    Ernst, Corinna
    BMC CANCER, 2022, 22 (01)
  • [37] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [38] Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers
    Angela George
    Current Genetic Medicine Reports, 2019, 7 : 116 - 123
  • [39] Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers
    George, Angela
    CURRENT GENETIC MEDICINE REPORTS, 2019, 7 (02) : 116 - 123
  • [40] Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant
    Hao, Jonathan Soon Jian
    Hoai, Chan Sock
    Weng, Daniel Tan Shao
    Ngeow, Joanne
    Chiang, Jianbang
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2022, 8 (07):
12345